IP Library › Granted Patent US 12,329,433
Granted Patent B2
US 12,329,433 · App. 17/251,939 · Granted Jun 17, 2025

Systems, devices, and methods for treatment of nasal disorders

Inventors: Brian Fahey (Menlo Park, CA); William Jason Fox (San Mateo, CA); Mojgan Saadat (Atherton, CA); Vahid Saadat (Atherton, CA)
Assignee: Arrinex, Inc.
A61B18/02A61B2018/00214A61B2018/00327A61B2018/00404A61B2018/00434A61B2018/00583A61B2018/00815A61B2018/00821A61B2018/00994
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,329,433
App. No.
17/251,939
Granted
Jun 17, 2025
Kind
B2
Abstract

Systems, devices, and methods involve ablation of tissue to treat rhinitis and/or other nasal conditions. Implementations allow treatment of tissue in the confined space of the nasal cavity. Additionally, implementations allow targeted treatment tissue to be ablated, while protecting other non-treatment tissue from unintentional collateral effects that might be produced by the ablation. According to an example implementation, an approach for treating a nasal condition includes advancing a probe into a nasal cavity, the probe including a shaft and a cryotherapy element coupled to the shaft. The approach also includes cryogenically cooling a target treatment site with the cryotherapy element to treat at least one nasal nerve. Additionally, the approach includes transmitting a focused ultrasound beam to a target heating site to increase a temperature tissue at the target heating site.

Claims (26)

1. A system for treating a nasal condition, the system comprising:

a probe including a shaft and a cryotherapy element coupled to the shaft, wherein the probe is configured to be advanced into a nasal cavity and to cryoablate treatment tissue including at least one nasal nerve at a target treatment site with the cryotherapy element; and

an ultrasound transducer assembly configured to transmit a focused ultrasound beam to non-treatment tissue at a target heating site to increase a temperature of the non-treatment tissue and to protect the non-treatment tissue from effects of cold temperature produced during cryoablation of the treatment tissue.

2. The system of claim 1 , wherein the cryotherapy element and the ultrasound transducer assembly are configured to cryoablate the treatment tissue at the target treatment site and transmit the focused ultrasound beam simultaneously.

3. The system of claim 1 , wherein the ultrasound transducer assembly is configured to initiate transmitting the focused ultrasound beam prior to the cryoablation of the treatment tissue at the target treatment site.

4. The system of claim 1 , wherein the ultrasound transducer assembly is coupled to the shaft.

5. The system of claim 4 , wherein the ultrasound transducer assembly is configured to transmit the focused ultrasound beam by emitting the focused ultrasound beam from the ultrasound transducer assembly at an angle relative to the shaft.

6. The system of claim 5 , wherein the ultrasound transducer assembly is configured so that the angle of the focused ultrasound beam is adjustable from a first angle wherein the focused ultrasound beam is directed in a first direction to a second angle wherein the focused ultrasound beam is directed in a second direction different than the first direction.

7. The system of claim 6 , wherein the ultrasound transducer assembly is configured so that the angle of the focused ultrasound beam is changed by articulating the angle of the ultrasound transducer assembly relative to the shaft.

8. The system of claim 6 , wherein the ultrasound transducer assembly is configured so that the angle of the focused ultrasound beam is changed with phased steering.

9. The system of claim 6 , wherein the ultrasound transducer assembly is configured so that while transmitting the focused ultrasound beam to the target heating site, the angle of the focused ultrasound beam relative to the shaft is changeable to transmit the focused ultrasound beam to multiple locations of the target heating site.

10. The system of claim 3 , wherein the ultrasound transducer assembly is slidably coupled to the shaft so that a position of the ultrasound transducer assembly along the shaft is changeable from a first position wherein the focused ultrasound beam is not directed to the target heating site to a second position wherein the focused ultrasound beam is directed to the target heating site.

11. The system of claim 3 , wherein the ultrasound transducer assembly is slidably coupled to the shaft so while transmitting the focused ultrasound beam to the target heating site a position of the ultrasound transducer assembly along the shaft is changeable to transmit the focused ultrasound beam to multiple locations of the target heating site.

12. The system of claim 4 , wherein the ultrasound transducer assembly is configured to transmit the focused ultrasound beam to identified target heating sites based upon a tissue temperature around the target treatment site while cryogenically cooling the target treatment site.

13. The system of claim 12 , further comprising a second ultrasound transducer assembly coupled to the shaft and configured to detect the tissue temperature.

14. The system of claim 13 , wherein the second ultrasound transducer assembly is configured to detect the tissue temperature while the ultrasound transducer assembly is transmitting the focused ultrasound beam to the target heating site.

15. The system of claim 12 , wherein the ultrasound transducer assembly is configured to detect the tissue temperature.

16. The system of claim 15 , further comprising a controller configured to detect the tissue temperature with thermal strain imaging.

17. The system of claim 12 , further comprising a temperature sensor comprising at least one of an infrared sensor, a thermocouple sensor, or a thermistor sensor, configured to detect the tissue temperature.

18. The system of claim 17 , wherein the temperature sensor is coupled to the shaft.

19. The system of claim 4 , further comprising a controller configured to determine a location of the target treatment site or the target heating site within the nasal cavity with the ultrasound transducer assembly or a second ultrasound transducer assembly coupled to the shaft.

20. A system for treating a nasal condition, the system comprising:

a probe including a shaft and a cryotherapy element coupled to the shaft, wherein the probe is configured to be advanced into a nasal cavity and to cryoablate treatment tissue including at least one nasal nerve at a target treatment site with the cryotherapy element;

a temperature sensor configured to detect a tissue temperature; and

a warming probe configured to be inserted into at least one of the nasal cavity to warm a non-treatment tissue to protect the non-treatment tissue from effects of cold temperature produced during cryoablation of the treatment tissue, wherein warming the non-treatment tissue comprises warming target heating sites identified based upon the temperature sensor detecting the tissue temperature around the target treatment site during cryoablation of the treatment tissue.

21. The system of claim 20 , wherein the warming probe includes a laser assembly configured to transmit a laser beam to the non-treatment tissue.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2026
From: ARRINEX, INC,
To: STRYKER CORPORATION
Reel/Frame 076101/0884 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2021
From: FAHEY, BRIAN; FOX, WILLIAM JASON; SAADAT, MOJGAN; SAADAT, VAHID
To: ARRINEX, INC.
Reel/Frame 054823/0664 →
Continuity (2)
Provisional Application 62690247 · Jun 26, 2018
Related Publication 20210369320A1 · Dec 2, 2021
References Cited (25)
US 3901241A · Allen, Jr. · 1975 [cited by applicant]
US 5843077A · Edwards · 1998 [cited by applicant]
US 6063079A · Hovda et al. · 2000 [cited by applicant]
US 6361531B1 · Hissong · 2002 [cited by examiner]
US 6378525B1 · Beyar et al. · 2002 [cited by applicant]
US 20070167776A1 · Kochavi · 2007 [cited by examiner]
US 20070225781A1 · Saadat · 2007 [cited by examiner]
US 20080027423A1 · Choi et al. · 2008 [cited by applicant]
US 20120184879A1 · Tanis · 2012 [cited by examiner]
US 20120323227A1 · Wolf et al. · 2012 [cited by applicant]
US 20140330124A1 · Carol · 2014 [cited by applicant]
US 20150164571A1 · Saadat · 2015 [cited by applicant]
US 20160045277A1 · Lin · 2016 [cited by examiner]
US 20160206373A1 · Chen et al. · 2016 [cited by applicant]
US 20160287334A1 · Grant et al. · 2016 [cited by applicant]
US 20160331459A1 · Townley · 2016 [cited by examiner]
US 20180344411A1 · Fahey · 2018 [cited by examiner]
CN 108024711A · 2018 [cited by applicant]
EP 2797516B9 · 2014 [cited by applicant]
WO 2016183337A2 · 2016 [cited by applicant]
Extended European Search Report issued by the European Patent Office in Application No. 23220526.0 dated Apr. 26, 2024. [cited by applicant]
Examination Report No. 1 issued by the Australian Patent Office in Application No. 2022231648 dated Jan. 15, 2024. [cited by applicant]
International Search Report mailed on Oct. 8, 2019, issued in connection with International Application No. PCT/US2019/039199, filed on Jun. 26, 2019, 5 pages. [cited by applicant]
Written Opinion mailed on Oct. 8, 2019, issued in connection with International Application No. PCT/US2019/039199, filed on Jun. 26, 2019, 8 pages. [cited by applicant]
Notice of Completing Formalities for Patent Registration issued by the Chinese Patent Office in Application No. 201980043227.5 dated Jun. 25, 2024. [cited by applicant]